Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We have shown previously that neutralizing antibodies (nAbs) are important contributors to the long-term immune control of lymphocytic choriomeningitis virus infection, particularly if cytotoxic T cell responses are low or absent. Nevertheless, virus escape from the nAb response due to mutations within the surface glycoprotein gene may subsequently allow the virus to persist. Here we show that most of the antibody-escape viral mutants retain their immunogenicity. We present evidence that the failure of the infected host to mount effective humoral responses against emerging neutralization-escape mutants correlates with the rapid loss of CD4(+) T cell responsiveness during the establishment of viral persistence. Similar mechanisms may contribute to the persistence of some human pathogens such as hepatitis B and C viruses, and human immunodeficiency virus.


Journal article


J Exp Med

Publication Date





297 - 305


Animals, Antibodies, Viral, Antigens, Viral, CD4-Positive T-Lymphocytes, Cell Line, Chronic Disease, Cricetinae, Genetic Variation, Glycoproteins, Humans, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus, Mice, Mice, Knockout, Mice, Transgenic, Neutralization Tests, Point Mutation, Viral Proteins